SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM. The company filed the application on 16 August with SGX Regco.
该公司于8月16日向新加坡证券交易所注册公司提交了申请。
The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing.
证券交易所的一份文件显示，新加坡先进医学研究所控股有限公司（SaM Holdings）申请延期提交其2024财年（2024财年）收益业绩的申请已获得新加坡交易监管（SGX Regco）的批准。
This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December.
这允许该公司延长两个月，以便在10月29日之前发布其2024财年业绩，并在12月31日之前召开年度股东大会（AGM）。
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM.
他们还获准在 12 月 16 日之前将 AR2024 的发行期限延长两个月，即股东周年大会日期的至少 14 天。
Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.
此外，预计该公司还将向会计和公司监管局（ACRA）申请延期2024年股东大会。
